In SARC, the TUBB mRNA expression level was negatively related to the abundance of B cells and CD8+ T which are both strongly immune-related cells and pivotal targets for cancer therapies (Wennhold et al., 2019; Chow et al., 2022; Lundberg et al., 2022). Here, CD8A is linked to cancer.